Searchable abstracts of presentations at key conferences in endocrinology

ea0050p056 | Bone and Calcium | SFEBES2017

Audit on parathyroid scans in patients with surgically managed primary hyperparathyroidism

Gherman-Ciolac Carolina , Lekkakou Leoni , Buch Harit

Background: Management of PHPT includes successful localization of parathyroid adenoma(s) by nuclear imaging and ultrasound scans allowing focused or minimally invasive surgery. Our aim was to assess the accuracy of parathyroid imaging in surgically-treated patients with primary hyperparathyroidism (PHPT) by correlating the imaging findings with surgical findings and cure of hyperparathyroidism. We also compared the surgical outcomes in patients with con...

ea0050p268 | Neuroendocrinology and Pituitary | SFEBES2017

Disorganised anterior pituitary ultrastructure in choriogonadotrophin-alpha (Cga) null female mice

Davies Jessica , Gergics Peter , Camper Sally , Christian Helen

Choriogonadotrophin-alpha (Cga) is one of the first molecular markers for the developing pituitary gland previously known as ‘alpha-subunit’, common to thyroid-stimulating hormone (TSH), luteinising hormone (LH) and follicle-stimulating hormone (FSH). Mice lacking Cga are hypogonadal and exhibit profound hypothyroidism and dwarfism. Light microscopy of Cga null mice has shown that pituitary thyrotrophs...

ea0050p343 | Obesity and Metabolism | SFEBES2017

The challenges of reducing calorie intake in everyday life- a pilot study

Joseph-Gubral Jude

One of the major risk factors for type 2 diabetes is Obesity (accounts for 80-85% of overall risk of developing type 2 diabetes). The UK is currently amid an obesity epidemic and it is recommended that the UK population reduce their daily calorie intake. As people are surrounded by food, it was acknowledged that this can be challenging to achieve on a long-term basis. This pilot study aimed to identify common social cues that encourage people to in...

ea0083pno3 | Pituitary and Neuroendocrinology | EYES2022

Development of novel immunoassays for the pro-opiomelanocortin joining peptide (A surrogate marker of adrenocorticotrophin levels) for use in the diagnosis of Cushing’s syndrome

M. Donnelly

Background: Excess adrenocorticotrophin (ACTH), most often from a pituitary tumour, results in the overproduction of cortisol and the condition, Cushing’s syndrome. Plasma ACTH measurements are used in the diagnosis of Cushing’s syndrome but due to the presence of multiple dibasic cleavage sites within its sequence, ACTH is extremely labile and far from an ideal analyte. Processing of ACTH by some ectopic tumours releases high levels of smaller-ACTH like fragments, &...

ea0084ps2-06-54 | Hypothyroidism Treatment | ETA2022

Treatment of hypothyroidism in europe by specialists: an international survey (THESIS): analysis of contested indications for prescribing among uk participants

R Younes Younes , Perros Petros , Hegedus Laszlo , Papini Enrico , V Nagy Endre , Attanasio (ORCID: 0000-0002-1417-287X) Roberto , Negro Roberto , C.T. Field (ORCID: 0000-0002-1883-1588) Benjamin

Objectives: We present findings from the UK arm of the THESIS collaboration, a pan-European survey of endocrinologists’ opinions and current practice in the management of hypothyroid and euthyroid disorders.Methods: UK clinical members of the Society of Endocrinology and the British Thyroid Association were invited to participate in an online survey.Results: 272 of 1295 (21%) eligible members completed the survey. More than 50...

ea0084ps2-10-87 | Nodules & Cancer | ETA2022

Toetva- scarless thyroid surgery in hungary

Levay Bernadett , Oberna Ferenc

In thyroid surgery recently is a very important issue to maintain good cosmesis of the scar which can always be visible. Even smaller incisions have been utilized in order to improve satisfaction of the patient. In the last decades new endoscopic techniques have been applied using breast or axillary approach with unfavourable cosmetic outcome In the last couple of years there has been a development of a new endocopic technique known as transoral endoscopic thyroidectomy vestib...

ea0086oc6.4 | Thyroid | SFEBES2022

Towards an automated app-based dose prescription of carbimazole for hyperthyroidism patients

Reich Thilo , Bakirov Rashid , Budka Dominika , Kelly Derek , Smith James , Richardson Tristan , Budka Marcin

University Hospitals Dorset (UHD) has over 1,000 thyroid patient contacts annually. These are primarily patients with autoimmune hyperthyroidism and are treated by titration of Carbimazole. Dose adjustments are made by a healthcare professional (HCP) based on the results of thyroid function tests. Once the test results are available, the HCP decides on a prescription dose and communicates this to the patient, which is time-consuming and introduces delays. This project aims to ...

ea0086op6.3 | Endocrine Cancer and Late Effects | SFEBES2022

Knockout mouse embryonic fibroblasts reveal a physiological role for the proto-oncogene PBF in cell adhesion and motility

Kocbiyik Merve , Manivannan Selvambigai , Brookes Katie , Zha Ling , Nieto Hannah R , Read Martin L , McCabe Christopher J , Smith Vicki E

The proto-oncogene pituitary tumor-transforming gene-binding factor (PBF) is upregulated in multiple tumours including thyroid cancer. PBF overexpression mediates tumorigenic processes such as cell motility and accelerates thyroid cancer cell invasion. We have recently shown that both PBF phosphorylation at tyrosine 174 (Y174) and PBF endocytosis are required for PBF-stimulated thyroid and breast cancer cell migration and invasion. This prompted further investigation into a ph...

ea0086p3 | Adrenal and Cardiovascular | SFEBES2022

Identification and characterization of a receptor for N-terminal pro-opiomelanocortin peptide

Alshammari Fatema , Bicknell Andrew , Lander Elizabeth

Background: Numerous studies have reported the role of the N-terminal of pro-opiomelanocortin (N-POMC1-76) and its smaller fragments; 1-28 and 1-49, in adrenal steroidogenesis and mitogenesis. A full understanding of this area will help to understand the pathophysiology of certain adrenal tumours but exactly how these peptides elicit this effect is unclear. We have recently identified an orphan G protein-coupled receptor (GPCR) as a possible N-POMC receptor. Preliminary data s...

ea0086p11 | Adrenal and Cardiovascular | SFEBES2022

Development of novel immunoassays for pro-opiomelanocortin (POMC)-derived peptides as surrogate markers of adrenocorticotrophin levels for use in the diagnosis of Cushing’s syndrome

Donnelly Megan , Lowry Philip , Gibbins Jon , Bicknell Andrew

Plasma adrenocorticotrophin (ACTH) is extremely labile and far from an ideal analyte for use in the diagnosis of Cushing’s syndrome. Processing of ACTH by some ectopic tumours releases high levels of smaller ACTH-like fragments, α-MSH and CLIP, which can interfere with individual antibodies in current diagnostic immunoassays. Furthermore, cross-reactivity with the precursor of ACTH, pro-opiomelanocortin (POMC), increases the likelihood of erroneous interpretations an...